These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 5978212)
21. Therapeutic equivalency of drugs. Fact or fiction? Stetler CJ Med Ann Dist Columbia; 1969 Jun; 38(6):297-300. PubMed ID: 5257886 [No Abstract] [Full Text] [Related]
22. HOW THE FOOD AND DRUG ADMINISTRATION EVALUATES NEW DRUG APPLICATIONS. LARRICK GP J New Drugs; 1964; 4(2):63-74. PubMed ID: 14197105 [No Abstract] [Full Text] [Related]
23. The development of orphan products. Finkel MJ N Engl J Med; 1982 Oct; 307(15):963-4. PubMed ID: 7110287 [No Abstract] [Full Text] [Related]
24. FDA attempting to overcome major roadblocks in monitoring drug safety. Zielinski SL J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645 [No Abstract] [Full Text] [Related]
25. The food and Drug Administration's view of investigational drugs. MEYERS EL SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340 [No Abstract] [Full Text] [Related]
26. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA. WESTON JK; WESTON K Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685 [No Abstract] [Full Text] [Related]
27. The learned intermediary doctrine: past, present and future. Alsobrook HB Leg Med; 1994; ():269-80. PubMed ID: 7830482 [No Abstract] [Full Text] [Related]
28. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
29. Biopharmaceutic equivalency and the role of the Food & Drug Administration. Hodges RM Am J Hosp Pharm; 1968 Mar; 25(3):121-7. PubMed ID: 5658859 [No Abstract] [Full Text] [Related]
30. Drug product liability and health care delivery systems. Sage WM Stanford Law Rev; 1988 Apr; 40(4):989-1026. PubMed ID: 10318110 [No Abstract] [Full Text] [Related]
31. FDA's regulation of prescription drug labeling: a role for implied preemption. Kendrick LC Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031 [No Abstract] [Full Text] [Related]
32. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate. Dorfman HL; Quinn VM; Brophy EA Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765 [No Abstract] [Full Text] [Related]
34. The final sampling regulations of the Prescription Drug Marketing Act are alive and well: is your sampling program compliant? Romanski JA Food Drug Law J; 2003; 58(4):649-60. PubMed ID: 15027455 [No Abstract] [Full Text] [Related]
35. Preparation and use of drug master files in the pharmaceutical industry. Personeus GR; Ascione P J Parenter Sci Technol; 1981; 35(2):63-9. PubMed ID: 7229835 [No Abstract] [Full Text] [Related]
36. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
37. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
38. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
39. The case for preemption of prescription drug failure-to-warn claims. Kim CH Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969 [No Abstract] [Full Text] [Related]
40. [Drug safety: the obligation of information recognized in Washington]. Chneiweiss H Med Sci (Paris); 2009 Mar; 25(3):317. PubMed ID: 19361399 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]